SAN FRANCISCO, June 18 /PRNewswire/ -- Burrill & Company, a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media, is pleased to announce that Shawn Cross has joined the firm as Managing Director, Merchant Banking. Shawn will assist clients in structuring and completing mergers and acquisitions, partnering and capital raising transactions. In addition, Shawn will make an important contribution to the collective efforts of the Burrill Merchant Banking Team in the formation and deployment of Burrill Private Equity funds. Shawn brings considerable experience in life science investment banking including:
- A twelve year career beginning at Alex. Brown & Sons Inc. where he focused on growth oriented companies and completed a broad range of transactions for leading life sciences companies such as Sepracor and United Therapeutics.
- Six years in London and New York City predominantly focused on mid and large-cap pharmaceutical companies - after Alex. Brown was acquired by Deutsche Bank AG in 1999 - including strategic advisory assignments for numerous European pharmaceutical companies such as Bayer AG in addition to book-running successful financings for emerging US companies such as Auxilium Pharmaceuticals and Sciele.
- An exclusive focus on growth-oriented life sciences companies at Thomas Weisel Partners LLC in San Francisco.
Mr. Cross received an MBA with Honors from
"We are delighted to have Shawn on board," said G. Steven Burrill, CEO of Burrill & Company. "Given the turmoil in the capital marke
|SOURCE Burrill & Company|
Copyright©2009 PR Newswire.
All rights reserved